Gleave, Robert J.; Beswick, Paul J.; Brown, Andrew J.; Giblin, Gerard M. P.; Haslam, Carl P.; Livermore, David; Moses, Andrew; Nicholson, Neville H.; Page, Lee W.; Slingsby, Brian; Swarbrick, Martin E. published their research in Bioorganic & Medicinal Chemistry Letters on December 1 ,2009. The article was titled 《2-Amino-5-aryl-pyridines as selective CB2 agonists: Synthesis and investigation of structure-activity relationships》.Related Products of 102645-33-0 The article contains the following contents:
2-Amino-5-aryl-pyridines e.g. I, had been identified as a synthetically tractable series of CB2 agonists from a high-throughput screen of the GlaxoSmithKline compound collection. The results of an investigation of the structure-activity relationships (SAR) which led to the identification a number of potent and selective agonists are described. After reading the article, we found that the author used 2,5-Dichloroisonicotinaldehyde(cas: 102645-33-0Related Products of 102645-33-0)
2,5-Dichloroisonicotinaldehyde(cas: 102645-33-0) belongs to pyridine. Pyridine, its benzo and pyridine-based compounds play diverse roles in organic chemistry. As ligands, solvents, and catalysts they facilitate reactions; thus descriptions of these new ligands and their applications abound each year.Related Products of 102645-33-0